Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy

由 Teppo, Hanna-Riikka, Soini, Ylermi, Karihtala, Peeter
發表在 Oxid Med Cell Longev (2017)

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

由 Hämäläinen, Mari, Teppo, Hanna-Riikka, Skarp, Sini, Haapasaari, Kirsi-Maria, Porvari, Katja, Vuopala, Katri, Kietzmann, Thomas, Karihtala, Peeter
發表在 Oxid Med Cell Longev (2019)

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP

由 Kari, Esa, Teppo, Hanna-Riikka, Haapasaari, Kirsi-Maria, Kuusisto, Milla Elvi Linnea, Lemma, Aurora, Karihtala, Peeter, Pirinen, Risto, Soini, Ylermi, Jantunen, Esa, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
發表在 J Clin Pathol (2019)

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation

由 Chan, Mikko C., Savela, Janette, Ollikainen, Riina K., Teppo, Hanna-Riikka, Miinalainen, Ilkka, Pirinen, Risto, Kari, Esa J. M., Kuitunen, Hanne, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi, Kuusisto, Milla E. L.
發表在 Oxid Med Cell Longev (2021)